Literature DB >> 6738577

Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.

E Mussini, F Cornelio, L Colombo, G De Ponte, G Giudici, L Cotellessa, F Marcucci.   

Abstract

Myofibrillar protein catabolic rate was calculated in 50 young patients with Duchenne muscular dystrophy from the amount of 3-methylhistidine excreted in the urine, and was found to be about seven times that of a control series, expressed as the percentage of myofibrillar protein catabolized per day. This wastage of myofibrillar protein is a consequence of Duchenne muscular dystrophy and inhibition of protein degradation appears to be one possible approach in the treatment of this disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738577     DOI: 10.1002/mus.880070508

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  3 in total

1.  Decrease in urinary excretion of 3-methylhistidine by patients with Duchenne muscular dystrophy during glucocorticoid treatment.

Authors:  H Kawai; K Adachi; Y Nishida; T Inui; C Kimura; S Saito
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

2.  Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.

Authors:  Jérémy Rouillon; Jérôme Poupiot; Aleksandar Zocevic; Fatima Amor; Thibaut Léger; Camille Garcia; Jean-Michel Camadro; Brenda Wong; Robin Pinilla; Jérémie Cosette; Anna M L Coenen-Stass; Graham Mcclorey; Thomas C Roberts; Matthew J A Wood; Laurent Servais; Bjarne Udd; Thomas Voit; Isabelle Richard; Fedor Svinartchouk
Journal:  Hum Mol Genet       Date:  2015-06-09       Impact factor: 6.150

3.  Long-term efficacy of systemic multiexon skipping targeting dystrophin exons 45-55 with a cocktail of vivo-morpholinos in mdx52 mice.

Authors:  Yusuke Echigoya; Yoshitsugu Aoki; Bailey Miskew; Dharminder Panesar; Aleksander Touznik; Tetsuya Nagata; Jun Tanihata; Akinori Nakamura; Kanneboyina Nagaraju; Toshifumi Yokota
Journal:  Mol Ther Nucleic Acids       Date:  2015-02-03       Impact factor: 10.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.